Clinical Trial Update: Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates that Phase 1/2 studies are recruiting to evaluate amiodarone-infused CardiaMend patches for preventing new-onset postoperat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Atrial Fibrillation

Drugs mentioned

• CardiaMend Amiodarone Patch (amiodarone)

Snippet

Sponsor: Helios Cardio Inc. | Conditions: Atrial Fibrillation, Postoperative | Phase 1, Phase 2 | Status: RECRUITING